1,792
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Effect of a high intake of cheese on cholesterol and metabolic syndrome: results of a randomized trial

, , &
Article: 27651 | Received 18 Feb 2015, Accepted 18 Jun 2015, Published online: 19 Aug 2015

References

  • Alwan A. Global status report on noncommunicable diseases 2010. 2011; World Health Organization. Available from: http://www.who.int/nmh/publications/ncd_report_full_en.pdf [cited 3 January 2015]..
  • TINE. Norvegia original. 2014. Available from: http://www.tine.no/merkevarer/norvegia/produkter/norvegia [cited 22 October 2014]..
  • Karanja NM, Obarzanek E, Lin PH, McCollough ML, Phillips KM, Swain JF, etal. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. J Am Diet Assoc. 1999; 99: S19–27.
  • Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, etal. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011; 123: 2292–333.
  • Høstmark AT, Tomten SE. The Oslo health study: cheese intake was negatively associated with the metabolic syndrome. J Am Coll Nutr. 2011; 30: 182–90.
  • Fumeron F, Lamri A, Abi Khalil C, Jaziri R, Porchay-Balderelli I, Lantieri O, etal. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a French prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2011; 34: 813–17.
  • Crichton GE, Alkerwi A. Dairy food intake is positively associated with cardiovascular health: findings from observation of cardiovascular risk factors in Luxembourg study. Nutr Res. 2014; 34: 1036–44.
  • Hjerpsted J, Leedo E, Tholstrup T. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am J Clin Nutr. 2011; 94: 1479–84.
  • Tholstrup T, Hoy CE, Andersen LN, Christensen RD, Sandstrom B. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently?. J Am Coll Nutr. 2004; 23: 169–76.
  • Sonestedt E, Wirfalt E, Wallstrom P, Gullberg B, Orho-Melander M, Hedblad B. Dairy products and its association with incidence of cardiovascular disease: the Malmo diet and cancer cohort. Eur J Epidemiol. 2011; 26: 609–18.
  • van Aerde MA, Soedamah-Muthu SS, Geleijnse JM, Snijder MB, Nijpels G, Stehouwer CD, etal. Dairy intake in relation to cardiovascular disease mortality and all-cause mortality: the Hoorn Study. Eur J Nutr. 2013; 52: 609–16.
  • Houston DK, Driver KE, Bush AJ, Kritchevsky SB. The association between cheese consumption and cardiovascular risk factors among adults. J Hum Nutr Diet. 2008; 21: 129–40.
  • Ohlsson L. Dairy products and plasma cholesterol levels. Food Nutr Res. 2010; 54: 5124.
  • Høstmark AT, Lunde MS. Cheese can reduce indexes that estimate fatty acid desaturation. Results from the Oslo Health Study and from experiments with human hepatoma cells. Appl Physiol Nutr Metab. 2012; 37: 31–9.
  • Nilsen R, Pripp AH, Høstmark AT, Haug A, Skeie S. Short communication: is consumption of a cheese rich in angiotensin-converting enzyme-inhibiting peptides, such as the Norwegian cheese Gamalost, associated with reduced blood pressure?. J Dairy Sci. 2014; 97: 2662–68.
  • Qureshi TM, Vegarud GE, Abrahamsen RK, Skeie S. Characterization of the Norwegian autochthonous cheese Gamalost and its angiotensin I-converting enzyme (ACE) inhibitory activity during ripening. Dairy Sci Technol. 2012; 92: 613–25.
  • Norwegian Institute of Public Health. The Oslo Health Study (HUBRO). 2005. Available from: http://www.fhi.no/artikler/?id=54464 [cited 12 August 2014]..
  • Pickering TG, Hall J, Appel LJ, Falkner BE, Graves J, Hill MN, etal. Recommendations for blood pressure measurement in humans and experimental animals. Hypertension. 2005; 45: 142–61.
  • WHO. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. 2011; Geneva, Switzerland: WHO.
  • Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, etal. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120: 1640–5.
  • U.S. Department of Health and Human Services. ATP III Guidelines at-a-glance quick desk reference. 2001. Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/atglance.pdf [cited 11 December 2014]..
  • American Heart Association. The American Heart Association's diet and lifestyle recommendations. 2014. Available from: http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/HealthyEating/The-American-Heart-Associations-Diet-and-Lifestyle-Recommendations_UCM_305855_Article.jsp [cited 11 March 2014]..
  • Sadeghi M, Khosravi-Boroujeni H, Sarrafzadegan N, Asgary S, Roohafza H, Gharipour M, etal. Cheese consumption in relation to cardiovascular risk factors among Iranian adults – IHHP Study. Nutr Res Pract. 2014; 8: 336–41.
  • Abreu S, Moreira P, Moreira C, Mota J, Moreira-Silva I, Santos PC, etal. Intake of milk, but not total dairy, yogurt, or cheese, is negatively associated with the clustering of cardiometabolic risk factors in adolescents. Nutr Res. 2014; 34: 48–57.
  • International Dairy Federation. Bulletin of the International Dairy Federation 470/2013 – The World Dairy Situation 2013. 2013; Brussels, Belgium: International Dairy Federation.
  • International Dairy Federation. Bulletin of the International Dairy Federation 476/2014 – The World Dairy Situation 2014. 2014; Brussels, Belgium: International Dairy Federation.
  • Biong AS, Muller H, Seljeflot I, Veierod MB, Pedersen JI. A comparison of the effects of cheese and butter on serum lipids, haemostatic variables and homocysteine. Br J Nutr. 2004; 92: 791–7.
  • Dugan CE, Fernandez ML. Effects of dairy on metabolic syndrome parameters: a review. Yale J Biol Med. 2014; 87: 135–47. [PubMed Abstract] [PubMed CentralFull Text].
  • Christensen R, Lorenzen JK, Svith CR, Bartels EM, Melanson EL, Saris WH, etal. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev. 2009; 10: 475–86.
  • Soerensen KV, Thorning TK, Astrup A, Kristensen M, Lorenzen JK. Effect of dairy calcium from cheese and milk on fecal fat excretion, blood lipids, and appetite in young men. Am J Clin Nutr. 2014; 99: 984–91.
  • Gould AL, Davies GM, Alemao E, Yin DD, Cook JR. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther. 2007; 29: 778–94.
  • Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, etal. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2224–60.
  • Samara A, Herbeth B, Ndiaye NC, Fumeron F, Billod S, Siest G, etal. Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study. Nutrition. 2013; 29: 519–24.
  • Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996; 3: 213–19.
  • Wu L, Ma D, Walton-Moss B, He Z. Effects of low-fat diet on serum lipids in premenopausal and postmenopausal women: a meta-analysis of randomized controlled trials. Menopause. 2014; 21: 89–99.
  • Fleming P, Godwin M. Low-glycaemic index diets in the management of blood lipids: a systematic review and meta-analysis. Fam Pract. 2013; 30: 485–91.
  • International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2006; Brussels, Belgium: IDF Communications.
  • Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, etal. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004; 164: 1066–76.
  • Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what is it and how to deal with it. Int J Epidemiol. 2005; 34: 215–20.